Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Clinical trial NCT02544438 · COMPLETED
Trial details
- NCT number
- NCT02544438
- Sponsor
- BioSight Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-09-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.